2-Methyl-2H-indazole-4-carboxylic acid

Catalog No.: 
ACSFPH251
CAS No.: 
1071433-06-1
Molecular Formula: 
C9H8N2O2
Molecular Weight: 
176.18
2-Methyl-2H-indazole-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$61.00In stockInquiry
250mg97%$74.00In stockInquiry
1g97%$89.00In stockInquiry
5g97%$232.00In stockInquiry
10g97%$389.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methyl-2H-indazole-4-carboxylic acid
IUPAC Name2-methyl-2H-indazole-4-carboxylic acid
MDL No.MFCD15071443
Molecular FormulaC9H8N2O2
Molecular Weight176.18
SMILESO=C(C1=CC=CC2=NN(C)C=C12)O
InChI KeyDPLXRRMSJKKHDU-UHFFFAOYSA-N
Synonym2-METHYL-2H-INDAZOLE-4-CARBOXYLIC ACID | 1071433-06-1 | 2-METHYLINDAZOLE-4-CARBOXYLIC ACID | SCHEMBL2011238 | DTXSID20597907 | MFCD15071443 | AKOS024126647 | PB19431 | AS-33609 | CS-0051871 | FT-0721732 | EN300-259904 | A895697 | J-509933 | W-204627 | Z1255366832
CAS No.1071433-06-1
PubChem CID19083173

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSFPH251 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSFPH251 route product structure diagram
    ACSFPH2511071433-06-1In Stock
Inquiry

2. ACSFPH251 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSFPH251 route product structure diagram
    ACSFPH2511071433-06-1In Stock
Inquiry

3. ACSFPH251 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSFPH251 route product structure diagram
    ACSFPH2511071433-06-1In Stock
Inquiry

Comments (0)